Since CD1a+ dDCs represent a large proportion of relatively mature dDCs with high expression levels of CCR7 suggesting a high migratory potential to draining lymph nodes [12], more research should be aimed at further investigating these cells in DC-targeted vaccination protocols to induce (anti-tumor) immune responses. Here, CD1A is linked to neoplasm.